InsiderClue
Insiders · Profile

Glickman Mark A

Co-Chief Executive Officer at TherapeuticsMD. Filing since 6 Dec 2022. CIK 0001441461

Company
Date
Role
Action
Shares
Amount
Of holding
TXMD TherapeuticsMD, Inc.
6 Dec 2022
Co-Chief Executive Officer
Sold, plan not stated
440
$2.17K
25.4%
1 decision on file.